中西医结合治疗慢性胃病临床研究

肖勇; 潘宇杰; 邢琦; 李伟; 江立富

doi:10.3969/j.issn.1006-0111.2015.05.022

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

重要提示

《药学实践与服务》杂志不接收生物战剂、毒剂相关内容的稿件。对于涉军信息类论文如需投稿，请务必投稿前电话或邮箱咨询。联系电话：021-81871323，邮箱：yxsjzzs@163.com。敬请谅解，谢谢配合！

《药学实践与服务》编辑部

免责声明

《药学实践与服务》杂志目前不收取审稿费、版面费、加急费等费用，如收到邮件声称是编辑部X编辑，要求加作者微信的，请谨防财产损失！编辑部用于作者校稿时微信绑定的邮件是通过yxsjzzs@163.com发送的，标题是《药学实践与服务》XML数字出版服务微信绑定，请区分开！

中西医结合治疗慢性胃病临床研究

肖勇, 潘宇杰, 邢琦, 李伟, 江立富

文章导航 > 药学实践与服务 > 2015 > 33(5): 460-462,476

肖勇, 潘宇杰, 邢琦, 李伟, 江立富. 中西医结合治疗慢性胃病临床研究[J]. 药学实践与服务, 2015, 33(5): 460-462,476. doi: 10.3969/j.issn.1006-0111.2015.05.022

引用本文:

肖勇, 潘宇杰, 邢琦, 李伟, 江立富. 中西医结合治疗慢性胃病临床研究[J]. 药学实践与服务, 2015, 33(5): 460-462,476. doi: 10.3969/j.issn.1006-0111.2015.05.022

XIAO Yong, PAN Yujie, XING Qi, LI Wei, JIANG Lifu. Combine traditional Chinese and western medicine treatment of chronic stomach disease clinical efficacy research[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 460-462,476. doi: 10.3969/j.issn.1006-0111.2015.05.022

Citation:

XIAO Yong, PAN Yujie, XING Qi, LI Wei, JIANG Lifu. Combine traditional Chinese and western medicine treatment of chronic stomach disease clinical efficacy research[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 460-462,476. doi: 10.3969/j.issn.1006-0111.2015.05.022

中西医结合治疗慢性胃病临床研究

doi: 10.3969/j.issn.1006-0111.2015.05.022

解放军5医院, 宁夏银川 750004

Combine traditional Chinese and western medicine treatment of chronic stomach disease clinical efficacy research

No. 5 Hospital of PLA, Yinchuan 750004, China

摘要: 目的探讨胃舒乐颗粒联用雷贝拉唑治疗慢性胃病的有效性。方法选择488例慢性胃病患者分为治疗组与对照组。对照组:口服雷贝拉唑肠溶胶囊,1次/d,20 mg/次;治疗组:在对照组基础上加服胃舒乐颗粒,3次/d,10 g/次,3周为1个疗程。分别比较两组疾病疗效、内镜检查及中医证型疗效。结果功能消化不良及浅表性胃炎治疗组与对照组比较,疗效有统计学差异 (P<0.01);萎缩性胃炎治疗组与对照组比较,疗效有统计学差异(P<0.05);治疗组与对照组内镜检查病变疗效比较,具有统计学差异(P<0.05)。中医证型疗效中,肝胃湿热证、肝气犯胃证治疗组与对照组比较,疗效差异显著,有统计学意义(P<0.01),胃络瘀血证、脾胃虚寒证、寒热夹杂证治疗组与对照组比较,疗效有统计学差异(P<0.05)。结论胃舒乐颗粒联用雷贝拉唑治疗慢性胃病临床总有效率、治愈率较高,未见不良反应。
- 慢性胃病 /
- 胃舒乐颗粒 /
- 雷贝拉唑 /
- 疗效
Abstract: Objective To investigate the effectiveness of the Weishule granule therapy with rabeprazole particles associated chronic stomach. Methods 488 cases of chronic gastritis were divided into treatment group and control group. Control group: oral rabeprazole enteric-coated capsules, 1 time/d, 20 mg/times; treatment groups: on the basis of additional services Weishule granules, 3 times/d, 10 g/ times, three weeks for a course respectively.The efficacy of two diseases, endoscopy and TCM syndromes were compared. Results The treatment effect among functional dyspepsia, gastritis treatment group and the control group had statistically difference (P<0.01); The treatment effect between atrophic gastritis treatment group and the control group was statistically difference (P<0.05); The efficacy of endoscopic lesions between the treatment group and the control group was statistically difference (P<0.05). TCM syndrome, the liver and stomach damp-heat syndrome, Fan Wei qi syndrome treatment group and the control group, had statistically difference (P<0.01), stomach meridian blood stasis, spleen deficiency syndrome, cold and heat mixture syndrome treatment group and the control group had statistically difference(P<0.05). Conclusion The effective rate and cure rate of Weishule granule combined rabeprazole azole in patients with chronic stomach trouble was better with less adverse reactions.
- chronic gastritis /
- Weishule granule /
- rabeprazole /
- clinical curative effect

[1]	孙斌,贾淑云,严海密,等.胃舒乐冲剂治疗功能性消化不良临床观察[J].宁夏医学杂志2003,25(2):107-108.
[2]	刘清萍, 晏峻峰,刘东波,等.理中汤超微粉与传统饮片临床疗效比较[J].中国医药信息杂志,2014,24(4):34-36.
[3]	郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:366-368.
[4]	陈澋珠, 林果为.实用内科学[M].上海:人民卫生出版社,2009:1973-1981.
[5]	周仲瑛.中医内科学[M].北京:中国中医药出版社,2003:71-100.
[6]	李乾构,周文学,单兆伟.中药消化病诊疗指南[M].北京:中国中医药出版社,2006:20-30.
[7]	李奕升,郭洪波,罗辉娥,等.加味左金丸治疗肝胃不和型食管炎临床研究[J].中国中医药信息杂志,2014,21(6):35-37.
[8]	陈建雄,陈赛里.慢性胃病治疗新概念[J].中国中医,2010,8(3):25-26.
[9]	司爱军.中医辨证治疗功能性消化不良的近远期疗效及安全性评价[J].现代中西医结合杂志,2014,23(4):372-374.

[1]	胡北, 崔亚玲, 马良煜, 许子华. 应用HPLC指纹图谱结合化学计量学对姜桂颗粒质量的评价研究 . 药学实践与服务, 2025, 43(10): 509-513. doi: 10.12206/j.issn.2097-2024.202312040
[2]	王文涛, 高兴, 赵凤平, 郑灿辉, 陈新. 异硒唑酮类化合物在疾病治疗中的作用和化学合成方法 . 药学实践与服务, 2025, 43(8): 367-372. doi: 10.12206/j.issn.2097-2024.202308064
[3]	张俊丽, 李媛媛, 尹静, 杨鸿源, 白耀武. 咪达唑仑调节PINK1/PARKIN信号通路对缺血性脑卒中大鼠神经元损伤的影响 . 药学实践与服务, 2025, 43(6): 288-292, 312. doi: 10.12206/j.issn.2097-2024.202405024
[4]	王菲, 张睿, 徐勇, 陈娴, 朱玉民. 瑞马唑仑用于术前镇静对患儿苏醒期谵妄的影响 . 药学实践与服务, 2025, 43(): 1-5. doi: 10.12206/j.issn.2097-2024.202411036
[5]	詹济华, 颜滢. 低蛋白血症对头孢哌酮舒巴坦血药浓度的影响 . 药学实践与服务, 2025, 43(7): 344-347. doi: 10.12206/j.issn.2097-2024.202309040
[6]	段虎, 周艳卿, 钱瑜琳, 赵亮. 某二级医院稳定期慢性阻塞性肺疾病患者吸入治疗依从性及其影响因素 . 药学实践与服务, 2025, 43(7): 362-366. doi: 10.12206/j.issn.2097-2024.202204094
[7]	陈官旭, 宋雨桐, 郭秀强, 张咪, 刘志宏, 宋洪涛. EGFR-TKIs单药及其联合方案在晚期非小细胞肺癌一线治疗中的疗效与安全性比较：网状Meta分析 . 药学实践与服务, 2025, 43(): 1-11. doi: 10.12206/j.issn.2097-2024.202504044
[8]	于翔, 贾培培, 李欣颖, 杨君君, 郭高峰, 陆连芳. M2型巨噬细胞外泌体喷剂对压力性损伤的疗效及作用机制 . 药学实践与服务, 2025, 43(9): 436-442. doi: 10.12206/j.issn.2097-2024.202503066
[9]	底雪梅, 帅文, 张其锵, 余梅香, 张海, 聂永红. 暖宫外敷方预防宫腔再粘连临床疗效回顾性分析 . 药学实践与服务, 2025, 43(7): 353-356. doi: 10.12206/j.issn.2097-2024.202411013
[10]	葛鹏程, 苏日古嘎, 任天舒, 党大胜. 硫酸黏菌素联合头孢哌酮舒巴坦治疗泛耐药鲍曼不动杆菌肺内感染的疗效分析 . 药学实践与服务, 2025, 43(): 1-4. doi: 10.12206/j.issn.2097-2024.202404093
[11]	闻韬, 焦广洋, 赵梦沛, 岳小强, 张凤, 陈万生. 基于UHPLC-Q-TOF/MS结合网络药理学研究柴胡桂枝干姜汤治疗慢性非萎缩性胃炎的物质基础及疗效机制 . 药学实践与服务, 2025, 43(9): 455-462. doi: 10.12206/j.issn.2097-2024.202312061
[12]	孟园园, 吴芸杨, 陈婷如, 顾秦五风, 杨延龙. 九味永安颗粒联合西替利嗪治疗湿疹湿热蕴肤证的临床疗效观察 . 药学实践与服务, 2025, 43(6): 298-302. doi: 10.12206/j.issn.2097-2024.202407045
[13]	王晓丹, 刘文杰, 宋畅, 董文星, 赵倩, 马骁龙. 利多卡因凝胶贴膏联合普瑞巴林治疗带状疱疹后神经痛患者疗效及对血清疼痛介质的影响 . 药学实践与服务, 2025, 43(11): 572-576. doi: 10.12206/j.issn.2097-2024.202505036
[14]	丁华敏, 郭羽晨, 秦春霞, 宋志兵, 孙莉莉. 消风止痒颗粒通过降低白三烯水平对小鼠特应性皮炎急性瘙痒的治疗作用研究 . 药学实践与服务, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031
[15]	桂明珠, 李静, 李志玲. 儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
[16]	陈方剑, 骆锦前, 王志君, 胡叶帅, 孙煜昕, 宋洪杰. HPLC-MS/MS同时测定感冒安颗粒中5种黄酮成分的含量 . 药学实践与服务, 2024, 42(9): 402-406. doi: 10.12206/j.issn.2097-2024.202403030
[17]	石晓萍, 吕迁洲, 李晓宇, 许青. 泊沙康唑对比伏立康唑经验治疗或诊断驱动治疗免疫功能低下患者侵袭性霉菌病的成本-效果分析 . 药学实践与服务, 2024, 42(12): 512-519. doi: 10.12206/j.issn.2097-2024.202401050
[18]	杨凤艳, 张月, 陈恩贤, 缪雪蓉, 魏凯. 瑞马唑仑临床应用研究进展 . 药学实践与服务, 2024, 42(9): 365-374. doi: 10.12206/j.issn.2097-2024.202405026
[19]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[20]	陈春娟, 郑志新, 李骊. 平喘方联合孟鲁司特钠治疗儿童支气管哮喘的临床疗效观察 . 药学实践与服务, 2024, 42(12): 524-527, 532. doi: 10.12206/j.issn.2097-2024.202405035

点击查看大图

计量

文章访问数: 4892
HTML全文浏览量: 624
PDF下载量: 520
被引次数: 0

中西医结合治疗慢性胃病临床研究

doi: 10.3969/j.issn.1006-0111.2015.05.022

解放军5医院, 宁夏银川 750004

收稿日期: 2014-09-23
修回日期: 2015-02-13

关键词:

摘要: 目的探讨胃舒乐颗粒联用雷贝拉唑治疗慢性胃病的有效性。方法选择488例慢性胃病患者分为治疗组与对照组。对照组:口服雷贝拉唑肠溶胶囊,1次/d,20 mg/次;治疗组:在对照组基础上加服胃舒乐颗粒,3次/d,10 g/次,3周为1个疗程。分别比较两组疾病疗效、内镜检查及中医证型疗效。结果功能消化不良及浅表性胃炎治疗组与对照组比较,疗效有统计学差异 (P<0.01);萎缩性胃炎治疗组与对照组比较,疗效有统计学差异(P<0.05);治疗组与对照组内镜检查病变疗效比较,具有统计学差异(P<0.05)。中医证型疗效中,肝胃湿热证、肝气犯胃证治疗组与对照组比较,疗效差异显著,有统计学意义(P<0.01),胃络瘀血证、脾胃虚寒证、寒热夹杂证治疗组与对照组比较,疗效有统计学差异(P<0.05)。结论胃舒乐颗粒联用雷贝拉唑治疗慢性胃病临床总有效率、治愈率较高,未见不良反应。

English Abstract

Combine traditional Chinese and western medicine treatment of chronic stomach disease clinical efficacy research

No. 5 Hospital of PLA, Yinchuan 750004, China

Received Date: 2014-09-23
Rev Recd Date: 2015-02-13

Keywords:

Abstract: Objective To investigate the effectiveness of the Weishule granule therapy with rabeprazole particles associated chronic stomach. Methods 488 cases of chronic gastritis were divided into treatment group and control group. Control group: oral rabeprazole enteric-coated capsules, 1 time/d, 20 mg/times; treatment groups: on the basis of additional services Weishule granules, 3 times/d, 10 g/ times, three weeks for a course respectively.The efficacy of two diseases, endoscopy and TCM syndromes were compared. Results The treatment effect among functional dyspepsia, gastritis treatment group and the control group had statistically difference (P<0.01); The treatment effect between atrophic gastritis treatment group and the control group was statistically difference (P<0.05); The efficacy of endoscopic lesions between the treatment group and the control group was statistically difference (P<0.05). TCM syndrome, the liver and stomach damp-heat syndrome, Fan Wei qi syndrome treatment group and the control group, had statistically difference (P<0.01), stomach meridian blood stasis, spleen deficiency syndrome, cold and heat mixture syndrome treatment group and the control group had statistically difference(P<0.05). Conclusion The effective rate and cure rate of Weishule granule combined rabeprazole azole in patients with chronic stomach trouble was better with less adverse reactions.